Pharmaceutical Industry

Page 9 of 100

Jo Natauri’s Invidia Capital seeks $850 million for first fund
Finance

Jo Natauri’s Invidia Capital seeks $850 million for first fund

By
October 31, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
Retail

British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance

By
October 30, 2024
A hand is seen holding Ozempic.
Health

Novo’s main Ozempic plant cited for quality lapses by FDA

By Madison Muller and Bloomberg
October 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life

Top aging expert says these 4 FDA-approved drugs hold promise for extending life

By
October 29, 2024
Sanofi profit lifted by early vaccine sales, dupixent growth
Finance

Sanofi profit lifted by early vaccine sales, dupixent growth

By Ashleigh Furlong, Tim Loh and Bloomberg
October 25, 2024
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
Commentary

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

By Jeffrey Sonnenfeld and Steven Tian
October 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
Health

Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination

By
October 22, 2024
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
Leadership

How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute

By
October 22, 2024
France's Prime Minister Michel Barnier speaking to reporters.
Health

French government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue

By Jurgen Hecker, Tom Barfield and AFP
October 22, 2024
Anne Wojcicki, chief executive officer and co-founder of 23andMe
Leadership

23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable

By
October 17, 2024
The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
Commentary

The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns

By
October 16, 2024
Walgreens to close 1,200 stores over next three years
Health

Walgreens to close 1,200 stores over next three years

By
October 15, 2024
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
Retail

France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache

By Jurgen Hecker and AFP
October 15, 2024
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Commentary

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

By Jeffrey Sonnenfeld and Steven Tian
October 10, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By
October 10, 2024

Most Popular